
Loading, please wait...

Loading, please wait...

Foodborne diseases represent a massive global health burden, causing approximately 420,000 deaths annually. In India, where food safety oversight faces systemic challenges, the need for rapid diagnostic tools is urgent. CRISPR food safety detection has emerged as a groundbreaking approach between 2020 and 2025, offering unprecedented sensitivity and speed compared to traditional culture-based methods.
Traditional assays like PCR often struggle with portability and long turnaround times. However, CRISPR-based biosensors utilize Cas proteins—specifically Cas12 and Cas13—to achieve high specificity. These systems can identify pathogens like Salmonella and E. coli within minutes rather than days. Consequently, this technology provides a critical safeguard for public health and clinical management of outbreaks.
Beyond simple pathogen identification, these biosensors address complex safety issues. For instance, they can detect food fraud by identifying animal species in meat products. Furthermore, researchers have adapted CRISPR systems to sense heavy metals, pesticide residues, and antibiotic contaminants. Because these tools are highly versatile, they serve as a comprehensive shield against diverse foodborne hazards.
Currently, the field is moving toward point-of-care testing (POCT) solutions. These devices are portable and require minimal laboratory infrastructure. Specifically, researchers are refining lateral flow assays to allow for on-site testing in low-resource settings. While some challenges like signal amplification remain, the future of food safety looks increasingly precise. Finally, integrating these sensors into the global supply chain could significantly reduce the incidence of preventable illnesses.
CRISPR/Cas systems offer faster results, often within 30 minutes, and do not always require the complex thermal cycling equipment needed for PCR. This makes them highly suitable for field-based testing and rapid screening.
These biosensors are versatile. They can detect viral and bacterial pathogens, chemical toxins, heavy metals, pesticide residues, and even identify food fraud through species-specific DNA detection.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
1. Niu Y et al. Harnessing CRISPR/Cas systems for food safety detection: biosensor design and emerging applications for food safety detection. Anal Methods. 2026 Feb 12. doi: 10.1039/d5ay01791b. PMID: 41676858.
2. Liberty JT et al. CRISPR revolution: Unleashing precision pathogen detection to safeguard public health and food safety. Methods. 2025 Apr 1. doi: 10.1016/j.ymeth.2025.04.018.
3. Sultana S et al. A review of CRISPR-Cas and PCR-based methods for the detection of animal species in the food chain. Food Addit Contam Part A. 2024;41(3):213-227.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive review of how CRISPR/Cas biosensors are revolutionizing the detection of foodborne pathogens, toxins, and food fraud for better public healt...
8 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today